Claire Rychlewski

Big deals that may have met resistance under the tough Biden antitrust regime could have an easier path.

An agreement has been signed on the deal that was announced in January.

Between them, the two PE firms can boast a robust pharma services investment portfolio.

Health investors like Trump

The last players standing may be eyeing mergers in a bid to survive and scale.

Millions of patients rely on retail pharmacies for their prescriptions — but these companies need to be more than that going forward.

Charlotte-based Petfolk has Miami and Phoenix on its list.

The company just bought durable medical equipment (DME) software company Bonafide and has eyes on larger deals.

Technology that makes clinical research more efficient is garnering investor interest.

The Abu Dhabi wealth fund agreed to anchor a "minority recapitalization" of the business.